"India is Shaping the Future of Global Life Sciences"

The Life Sciences industry in India is experiencing a remarkable surge, driven by a growing emphasis on precision medicine, biotechnology, and advanced diagnostics. We're seeing increased investment in research infrastructure, talent development, and innovation hubs across the country. At HORIBA, we're proud to support this momentum by providing analytical solutions that empower scientists, clinicians, and manufacturers to push boundaries and deliver meaningful outcomes.

- Dr. Rajeev Gautam, Senior Corporate Officer, HORIBA Ltd. & President, HORIBA India

"India is not just catching up—it's shaping the future of global life sciences."

You have had an inspiring professional journey with deep contributions to life sciences and diagnostics. Looking back, what pivotal moments shaped your leadership style and long-term vision for the bio & healthcare sector?

My journey has been shaped by a passion for science and its ability to drive meaningful change. At HORIBA India, leading the Life Sciences and Diagnostics segments has shown me how advanced analytics can transform healthcare—from early disease detection to precision research. Pivotal moments include expanding access to diagnostic tools and supporting researchers with technologies that decode cellular behavior and bioprocess dynamics. I envision a healthcare ecosystem where innovation meets accessibility, and where India leads in delivering scalable, data-driven solutions across diagnostics, therapeutics, and life sciences— empowering both clinicians and scientists to improve lives.

How do you see India's healthcare and diagnostics ecosystem evolving in the next 5-10 years, especially with the growing emphasis on digital health, Al, and precision medicine?